MILLAN NUNEZ CORTES, Jesús    SOCIEDAD ESPANOLA DE ARTERIOSCLEROSIS. Comité Científico del Registro de Hipertrigliceridemias et al. Metabolic syndrome in patients with clinical phenotype "hypertriglyceridemic waist". []. , 32, 3, pp.1145-1152. ISSN 1699-5198.  https://dx.doi.org/10.3305/nh.2015.32.3.9138.

Introduction: hypertriglyceridemic waist phenotype has been associated with metabolic syndrome. Objetives: in the present work has been raised to study the relationship between hypertriglyceridemic waist phenotype and metabolic syndrome as well as other metabolic risk factors. And finally, assess whether it is associated with an increased cardiovascular risk. Methods: this study was conducted recruiting patients in a national registry of hypertriglyceridemia of the Spanish Society of Artherosclerosis. The total number of patients included in the present study was 1 369. The criteria used to define the increased waist perimeter and metabolic syndrome were based on those established by the ATPIII or IDF, respectively. Results: hypertriglyceridemic waist prevalence in patients with hypertriglyceridemia was near to 50% and 80% using ATPII and IDF anthropometric criteria, respectively. The prevalence of metabolic syndrome in these patients was close to 97% (ATPIII criteria) and 63% (IDF criteria). Also was significantly higher prevalence of hypertension and diabetes mellitus type 2. However, the association with cardiovascular disease does not depend on the existence of hypertriglyceridemic waist phenotype, but the existence (or not) of metabolic syndrome. Conclusions: the CHTG can be used in clinical practice routine as a marker of metabolic alterations.

: Hypertriglyceridemic waist; Metabolic syndrome; Cardiovascular risk; Diabetes mellitus; Cholesterol-HDL.

        · |     · |     · ( pdf )